A
$ Value
$0
Shares
36,150
Price
$0
Filed
Feb 3
Insider
Name
Siegrist Jonathan Philip
Title
EVP of R&D & CTO
CIK
0002040321
Roles
Officer
Transaction Details
Transaction Date
2026-01-30
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
36,150
Footnotes
Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation Common Stock. | 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029. | 36,150 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029.
Filing Info
Siegrist Jonathan Philip's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-30 | QDEL | A | $0 |
| 2026-01-30 | QDEL | A | $0 |
| 2026-01-29 | QDEL | A | $0 |
| 2026-01-29 | QDEL | F | $28K |
| 2026-01-29 | QDEL | M | $0 |
| 2025-10-15 | QDEL | A | $0 |
| 2025-10-15 | QDEL | F | $182K |
| 2025-10-15 | QDEL | M | $0 |
Other Insiders at QDEL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Blaser Brian J.
President and CEO
|
$249K | — | 2026-02-13 |
| Strobeck Matthew | $240K | — | 2026-02-13 |
|
Busky Joseph M.
Chief Financial Officer
|
$80K | — | 2026-03-28 |
|
SISITSKY NATHANIEL
Chief Legal Officer
|
— | — | 2026-04-15 |
|
Hodges Michelle A
Chief Legal Officer
|
— | — | 2026-02-08 |
|
Bowman Ronald Lee
Chief Human Resources Officer
|
— | — | 2026-01-30 |
|
Siegrist Jonathan Philip
EVP of R&D & CTO
|
— | — | 2026-01-30 |
|
McLellan Philip D.
Chief Operations Officer
|
— | — | 2026-01-31 |